Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. The company's product pipeline includes Fasedienol, an i...
Q4 2026
Jun 16, 2026
Q3 2026
Feb 12, 2026
Q2 2026
Nov 13, 2025
Q1 2026
Aug 7, 2025
FY 2025
Jun 17, 2025
